Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Arfaptin	ARFIP1 ICA1L	3.60e-05	5	36	2	PF06456
Domain	Arfaptin	ARFIP1 ICA1L	3.60e-05	5	36	2	SM01015
Domain	AH_dom	ARFIP1 ICA1L	3.60e-05	5	36	2	IPR010504
Domain	AH	ARFIP1 ICA1L	3.60e-05	5	36	2	PS50870
Domain	FAM26	CALHM5 CALHM1	5.39e-05	6	36	2	IPR029569
Domain	Ca_hom_mod	CALHM5 CALHM1	5.39e-05	6	36	2	PF14798
Domain	-	ARFIP1 ICA1L	1.52e-03	30	36	2	1.20.1270.60
Domain	AH/BAR-dom	ARFIP1 ICA1L	1.52e-03	30	36	2	IPR027267
Pathway	REACTOME_NEUROTRANSMITTER_CLEARANCE	BCHE MAOA	1.51e-04	11	24	2	M26914
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ZNF106 DIP2A QARS1 MAP4K4 TOPAZ1	1.75e-04	497	37	5	36774506
Pubmed	A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.	ZNF106 CSE1L RFC1	3.22e-04	125	37	3	21654808
Pubmed	Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice.	TTLL9 AGBL3	3.25e-04	25	37	2	29593216
Pubmed	Genome-wide analysis of translation reveals a critical role for deleted in azoospermia-like (Dazl) at the oocyte-to-zygote transition.	QARS1 MOS	5.35e-04	32	37	2	21460039
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	RFC1 QARS1 CDC45	5.49e-04	150	37	3	30154076
Pubmed	The human plasma proteome: a nonredundant list developed by combination of four separate sources.	BCHE CSE1L ITIH4	7.24e-04	165	37	3	14718574
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	PDZD8 CSE1L QARS1 ARFIP1 MAP4K4	8.76e-04	708	37	5	39231216
Pubmed	Association study of 182 candidate genes in anorexia nervosa.	MAOA RGS13 GLP2R	9.61e-04	182	37	3	20468064
Pubmed	An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.	ZNF106 RASA2	9.67e-04	43	37	2	30975701
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	DIP2A CSE1L TOPAZ1 EML6	1.01e-03	420	37	4	28065597
Cytoband	7q21.3	CASD1 TECPR1	4.60e-04	39	37	2	7q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q31	KCNT2 RGS13	1.69e-03	75	37	2	chr1q31
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	QARS1 TOPAZ1 ITIH4	2.11e-03	316	37	3	chr3p21
Cytoband	3p21.31	QARS1 TOPAZ1	2.98e-03	100	37	2	3p21.31
Cytoband	Ensembl 112 genes in cytogenetic band chr7q21	CASD1 TECPR1	9.11e-03	178	37	2	chr7q21
Cytoband	Ensembl 112 genes in cytogenetic band chr3q26	PHC3 BCHE	1.32e-02	216	37	2	chr3q26
GeneFamily	Classical BAR domain containing	ARFIP1 ICA1L	3.94e-05	8	22	2	1292
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6\|TCGA-Colorectal / Sample_Type by Project: Shred V9	BCHE ANO5 RGS13 GLP2R	1.13e-05	168	37	4	5ce3129a023a48a3d7e6b9306c1fc5addfef9675
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PHC3 RASA2 ITIH4 CD101	1.15e-05	169	37	4	8caf7996796a2e2716e3855de855c903d6126bf2
Drug	N,N'-monomethylenebis(pyridiniumaldoxime)	BCHE MAOA	7.70e-06	3	37	2	ctd:C005514
Drug	1,5-dihydroxyxanthone	BCHE MAOA	7.70e-06	3	37	2	CID005480299
Drug	Trimedoxime	BCHE MAOA	1.54e-05	4	37	2	ctd:D014289
Drug	N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine	BCHE MAOA	1.54e-05	4	37	2	ctd:C570530
Drug	Obidoxime Chloride	BCHE MAOA	2.56e-05	5	37	2	ctd:D009768
Drug	desoxypeganine	BCHE MAOA	3.84e-05	6	37	2	CID000442894
Drug	salsolidine	BCHE MAOA	5.37e-05	7	37	2	CID000010302
Drug	pralidoxime	BCHE MAOA	7.15e-05	8	37	2	ctd:C028797
Drug	TMBs	BCHE MOS	9.18e-05	9	37	2	CID000076113
Drug	NIK-247	BCHE MAOA	1.15e-04	10	37	2	CID000604519
Drug	hexetone	BCHE MOS	1.15e-04	10	37	2	CID000222994
Drug	AC1L2FXT	PHC3 BCHE	1.15e-04	10	37	2	CID000071316
Drug	2,2'-dithiodipyridine	BCHE MAOA ITIH4	1.40e-04	62	37	3	CID000065093
Drug	HLA20	BCHE MAOA	1.68e-04	12	37	2	CID006918819
Drug	AC1L2XIZ	PHC3 BCHE	1.68e-04	12	37	2	CID000104803
Drug	2 HR	BCHE MAOA ITIH4	1.76e-04	67	37	3	CID006398363
Drug	Ms 8209	MAOA ITIH4	2.66e-04	15	37	2	CID000072368
Drug	asoxime chloride	BCHE MAOA	2.66e-04	15	37	2	ctd:C022870
Drug	aminochrome	BCHE MAOA	4.32e-04	19	37	2	CID000170262
Drug	diethylaminoethanol	BCHE ITIH4	4.32e-04	19	37	2	CID000007497
Drug	methyl phosphate	BCHE QARS1	4.79e-04	20	37	2	CID000013130
Drug	alpha-Te	BCHE MAOA	4.79e-04	20	37	2	CID000023353
Drug	alamos	ITIH4 MOS	7.53e-04	25	37	2	CID000079914
Drug	neodymium	BCHE NDN MAOA	8.61e-04	115	37	3	CID000023934
Drug	methylcarbamate	BCHE MAOA	1.01e-03	29	37	2	CID000011722
Drug	AC1L9JS4	CSE1L MAOA MOS	1.10e-03	125	37	3	CID000446532
Drug	diisopropyl	BCHE MOS	1.56e-03	36	37	2	CID000006589
Disease	Cognition Disorders	BCHE MAOA	8.31e-04	38	33	2	C0009241

Protein segments in the cluster

Peptide	Gene	Start	Entry
ATCRNIKKYSTSWTA	AGBL3	866	Q8NEM8
LSRSIVKRWANFAKY	BCHE	491	P06276
DYWRLNSTCLASKFS	ANO5	361	Q75V66
CWVNYLLKAKGRRST	CATSPERE	336	Q5SY80
ELVRKWSLNTYKCTR	ARFIP1	126	P53367
RPCFTQAAFLKSKYW	CALHM1	206	Q8IU99
VFSWSSCSRQYLKKF	ADAMTS18	471	Q8TE60
NRRSSAYKWKETLFS	ITIH4	806	Q14624
FKKRWFCLTSRELTY	RASA2	626	Q15283
IDKICWTKTARRFAY	MAOA	161	P21397
YKKRFNSEILCAALW	MAP4K4	921	O95819
ALWLKRVCYERTSFS	MBOAT2	346	Q6ZWT7
AWKFRAATQCEFSRK	DCUN1D2	106	Q6PH85
YRNKLGKWTRTRASC	PDZD8	686	Q8NEN9
WIRTYARLYQKLCSS	KCNT2	936	Q6UVM3
RYNVSCSKKFALSRW	PHC3	811	Q8NDX5
YQKCLVASAARGKAW	APBB3	411	O95704
CNTSYTAARFKLWSV	CDC45	291	O75419
CLYWKARKLSTLRSN	CD101	976	Q93033
ETTRKWAQYKQACLR	GLP2R	71	O95838
FLTYSIWASSCKNKA	CASD1	651	Q96PB1
ARCRSKVSYLQLSFW	CALHM5	201	Q8N5C1
YKGLSIRSVCWKADR	EML6	281	Q6ZMW3
SWIQKVCFYKARAAL	DIP2A	591	Q14689
TYQRTLLGFWKKTAR	ICA1L	226	Q8NDH6
ACETYKKIASRWSRI	RGS13	66	O14921
KCTKNRLASRRSFWA	MOS	91	P00540
CTKEFQARRSSYFWL	QARS1	456	P47897
LSYVAFCKKWATKTR	UTP6	111	Q9NYH9
WCARSKALTYDQAKA	RFC1	821	P35251
NIRDAKKRTALYWAC	ANKRD30BL	66	A7E2S9
CASVTFKNYIKRNWR	CSE1L	61	P55060
ATYTKDKKWNSCVRR	TECPR1	146	Q7Z6L1
CWKKASLPESSYFLR	TOPAZ1	506	Q8N9V7
CKWTLQRFRQYLASK	TTLL9	271	Q3SXZ7
LKCRWKNCDAFFTAR	ZNF106	1846	Q9H2Y7
SYKKWCRSILRRTSL	NDN	131	Q99608